• Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Bulgaria Czechia Denmark France +6
  • Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Czechia France Germany Greece Hungary Italy +4
  • Study on Rivaroxaban, Dabigatran Etexilate, and Fluindione for Patients with Intra-Cardiac Thrombus

    Not recruiting

    3 1 1 1
    France
  • Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Germany Hungary Italy +6
  • Study on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Poland Spain
  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Bulgaria France Germany Italy Poland +1
  • Study on Tolcapone for Improving Cognitive Symptoms in Patients with Long-Standing Schizophrenia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of LB-100 plus doxorubicin compared to doxorubicin alone in adults with advanced soft tissue sarcomas as first-line treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Effects of Ezabenlimab and BI 907828 in Adult Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1
    Sweden

powered by